11 Recruiting Acute Myeloid Leukemia Clinical Trials in Florida
Explore active acute myeloid leukemia research studies enrolling across Florida. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Acute Myeloid Leukemia Studies in Florida
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
📍 H Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
📍 Johns Hopkins All Children's Hospital — St. Petersburg, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
📍 University of Miami Sylvester Comprehensive Cancer Center — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
📍 Mayo Clinic Cancer Center — Jacksonville, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy
📍 University of Miami — Miami, Florida
View Study & Checklist ➔